Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Based on cross-trial comparison, the 12 mg retatrutide dose (28.3% at 80 weeks) exceeds tirzepatide's SURMOUNT-1 result (22.5% at 72 weeks) by roughly 6 percentage points
While they're in Boston at Harvard, they meet with a guy named Elliott Joslin
/assets/images/provider/photos/2775922.jpeg)
Below we cover the mechanism difference, the SURMOUNT-5 numbers in depth, the side effect reality week by week, the 2026 cost map across four purchase paths, who each drug is best for, and what happens when you stop or switch drugs mid-protocol
Type 1 diabetes mellitus and risk of cancer: a meta-analysis of observational studies
US$ 29.66
US$ 24.25
US$ 20.69
US$ 20.03
US$ 27.27
